LifeMD LFMD 深 沪
等待开盘 09-18 09:30:00 美东时间
6.08
+0.070
+1.16%
华盛通- 最 高6.25
- 今 开5.99
- 成交量 125.46万股
- 最 低 5.985
- 昨 收 6.01
- 总市值 2.88亿
- 52周最高 15.84
- 市盈率 静 --
- 换手率 2.65%
- 52周最低 3.99
- 委 比 69.54%
- 总股本 4741.74万
- 历史最高 33.02
- 量 比 1.10
- 振 幅 4.41%
- 历史最低 1.14
- 每 手 1
- 风险率 2.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its ex...
09-10 06:24
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Sept. 1, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been ...
09-02 00:00
LifeMD rises as KeyBanc says telehealth revenue increasing
LifeMD (NASDAQ:LFMD) is up ~3% in Wednesday trading after KeyBanc Capital Markets issued a bullish note on the telehealth provider. The bank said that proprietary cardholder data for LifeMD and its Re...
08-21 01:52
诺和诺德将向符合条件的美国客户提供每月499美元的Ozempic药物
诺和诺德公司周一表示，将向美国符合条件的 2 型糖尿病自费患者提供每月 499 美元的糖尿病药物 Ozempic。 本月早些时候，该公司曾表示，预计今年其重...
08-18 22:08
美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
08-07 09:46
Keybanc Maintains Overweight on LifeMD, Lowers Price Target to $12
Keybanc analyst Scott Schoenhaus maintains LifeMD (NASDAQ:LFMD) with a Overweight and lowers the price target from $14 to $12.
08-06 21:51
Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Shares of Astera Labs, Inc. (NASDAQ:ALAB) rose sharply in pre-market trading af...
08-06 17:35
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers BiomX (AMEX:PHGE) shares moved upwards by 40.1% to $0.61 during Tuesda...
08-06 05:07
LifeMD Affirms FY2025 Sales Guidance of $268.000M-$275.000M vs $270.357M Est
LifeMD (NASDAQ:LFMD) affirms FY2025 sales outlook from $268.000 million-$275.000 million to $268.000 million-$275.000 million vs $270.357 million estimate.
08-06 04:08
美股牛股 | 康普单日飙涨86%！获安费诺收购宽带业务；法拉第未来新车型进入试产阶段
康普单日飙涨86%！获安费诺收购宽带业务；法拉第未来隔夜涨近20%，新车型FX Super One进入试产阶段>>
08-05 17:07
